BioPharm International
February 01, 2008
Features
21
2
Two case studies illustrate a systematic approach.
February 01, 2008
Columns and Departments
21
2
The much needed modernization of the agency's IT systems and inspection capabilities will likely fall prey to budget shortfalls.
February 01, 2008
Columns and Departments
21
2
The use of disposables has changed significantly in the biopharmaceutical industry.
February 01, 2008
Columns and Departments
21
2
Both innovator and generics companies are using analytics to support comparability arguments.
February 01, 2008
Columns and Departments
21
2
In our increasingly global industry; foreign manufacturing inspections are more important than ever.
February 01, 2008
Features
21
2
Best practices from Big Biotech, including how to handle new product introductions.
February 01, 2008
Columns and Departments
21
2
The key to a good graphical presentation is to select the method that best fits the data.
February 01, 2008
Columns and Departments
21
2
Indian biogenerics could form a major piece of the global biotherapeutics market in the future.
February 01, 2008
Features
21
2
Putting business principles to work in biotechs requires careful implementation of nine critical business systems.